Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 6

Prosthetic heart valves and warfarin usage

Protez kapaklar ve warfarin kullanımı

Pages
392–399
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we tried to revise the effects, usage and precautions of warfarin in which plays an important role in surgical treatment of heart valve diseases and influences the success of applications for cardiovascular problems affecting life and quality of life

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this review, we tried to revise the effects, usage and precautions of warfarin in which plays an important role in surgical treatment of heart valve diseases and influences the success of applications for cardiovascular problems affecting life and quality of life
📊
Key Findings & Data:In this review, we tried to revise the effects, usage and precautions of warfarin in which plays an important role in surgical treatment of heart valve diseases and influences the success of applications for cardiovascular problems affecting life and quality of life
💡
Conclusion & Impact:In this review, we tried to revise the effects, usage and precautions of warfarin in which plays an important role in surgical treatment of heart valve diseases and influences the success of applications for cardiovascular problems affecting life and quality of life
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kalp kapağı protezleri · Varfarin · Kalp kapağı protezi implantasyonu

Abstract

In this review, we tried to revise the effects, usage and precautions of warfarin in which plays an important role in surgical treatment of heart valve diseases and influences the success of applications for cardiovascular problems affecting life and quality of life

Özet

Bu derlemede, kalp kapak hastalıklarının cerrahi tedavisi sonrasında önemli bir yer tutan, uygulamanın başarısını etkileyen önemli bir ilaç olan warfarinin etkisini, kullanımını ve kullanımı konusunda dikkat edilmesi gereken hususları gözden geçirilmeye çalıştık.

🔖

Cite This Article

ŞAHİN, M. A., TATAR, T., KÜÇÜKARSLAN, N., SAĞ, C., ÖZAL, E. (2006). Prosthetic heart valves and warfarin usage. MN Kardiyoloji, Cilt: 13 - Sayı: 6, 392–399. https://ajindex.com/articles/297534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Enver Duran Kalp ve Damar Cerrahisi Cilt 2 p;1193. Ünlü M, İyisoy A, Köse S, Kurşaklıoğlu H, Işık E. Gülhane Askeri Tıp Akademisi, Ayın Kitabı, Kasım. Protez Kalp Kapakları 2004: 1-5.
  2. Ira Goldsmith, Alexander G G Turpie and Gregory Y H Lip. ABC of antithrombotic therapy: Valvar heart disease and prosthetic heart valves. BMJ 2002; 325:1228-31. Fidel Manuel Câceras-Löriga, JHoracio Perez-Lopez, Jose Santos-Gracia, Karel Morlans-Hernandez. Prosthetic heart valve thrombozis: Pathogehesis, diagnosis and management, internal Journal of Cardiology 110(2006);1-6.
  3. Deeb N. Salem, Paul D. Stein, Amin Al-Ahmad, Henry I. Buşsey, Dieter Horstkotte, Nancy Miller, Stephen G.Pauker. Antithrombotic therapy in valvular heart disease-Native and Prosthetic: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126:457-82.
  4. Cannegieter SÇ, Rösendaal FR, Briet E. Thrornboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89:635-41.
  5. Cannegieter SC, Rösendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Eng J Med 1995; 333:11 -17. Bain-Ebell J, Schuster C, Elert O. Influence of valve size on morbidity and mortality for patients with mechanical valve replacement (GELİA 8). Eur Heart J 2001; Suppl 3(Q):73-77.
  6. Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Yoshida K, Tokudo Y, Matsua T. Anticoagulant therapy in Japanese patients with mechanical mitral valves. Circ J 2002; 66:668-670.
  7. Levine MN, Raskob G, Landefeld S, Kaeron C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119:108S-121S. Kudicky D, Essop MR, Wisenbaugh T, Skoularigis J, Essop AR, Dullabh A, et al. Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St Jude Medical prostheses. Am J Cardiol 1994; 74:1137-41.
  8. Cortelazzo S, Finazzi G, Galli M, Remuzzi A, Parenzan L, Barbui T. Thromboembolic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993;69:316-20.
  9. Baudet EM, Oca CC, Rogues XF, et al. A 51/2 year experience with the ST Jude Medical acrdiac valve prosthesis: early and late results of 737 valve replacements in 671 patients. J Thorac Cardiovasc Surg 1985; 90:137-144.
  10. Mavitaş B, Yamak B, Sarıtaş A, İşcan H. Z, Erdil N, Ulus A. T, Katırcıoğlu S. F, Şener E, Taşdemir O, Bayazıt